ASNC has confirmed reports that supply disruptions with both Tc-99m pyrophosphate (PYP) and Tc-99m hydroxymethylene diphosphonate (HMDP or HDP) may take place after January 2026. These products are used in the diagnosis of cardiac amyloidosis.
ASNC is in contact with the manufacturers of both products to understand the extent of the shortages and the projected timelines for resuming production.
ASNC will share updates as this issue evolves. To be among the first to receive email alerts with breaking news, be sure to keep your ASNC membership current.
Article Type
News & Announcements
Category
Advocacy
Related Posts
Check Now! Are You on CMS’s Heart Failure Payment Model List?
“ASNC Members, it is critically important that you check the CMS website…
Cardiovascular Societies Ask OMB to Withdraw Proposal Affecting Research Grants
ASNC joined the American College of Cardiology and other cardiovascular societies in…
CMS Issues Proposed Rule for 2027 Medicare Physician Fee Schedule
On July 14, the Centers for Medicare & Medicaid Services (CMS) released…

